120 related articles for article (PubMed ID: 30143154)
21. A trade-off between solubility enhancement and physical stability upon simultaneous amorphization and nanonization of curcumin in comparison to amorphization alone.
Wong JJL; Yu H; Lim LM; Hadinoto K
Eur J Pharm Sci; 2018 Mar; 114():356-363. PubMed ID: 29309874
[TBL] [Abstract][Full Text] [Related]
22. Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion.
Six K; Daems T; de Hoon J; Van Hecken A; Depre M; Bouche MP; Prinsen P; Verreck G; Peeters J; Brewster ME; Van den Mooter G
Eur J Pharm Sci; 2005 Feb; 24(2-3):179-86. PubMed ID: 15661489
[TBL] [Abstract][Full Text] [Related]
23. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices.
Li B; Konecke S; Wegiel LA; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Oct; 98(1):1108-16. PubMed ID: 23987452
[TBL] [Abstract][Full Text] [Related]
24. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging.
Ewing AV; Clarke GS; Kazarian SG
Eur J Pharm Sci; 2014 Aug; 60():64-71. PubMed ID: 24832964
[TBL] [Abstract][Full Text] [Related]
25. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
26. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
[TBL] [Abstract][Full Text] [Related]
27. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
[TBL] [Abstract][Full Text] [Related]
28. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
Dukeck R; Sieger P; Karmwar P
Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
[TBL] [Abstract][Full Text] [Related]
29. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
30. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
Konno H; Handa T; Alonzo DE; Taylor LS
Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
[TBL] [Abstract][Full Text] [Related]
31. Solubilization of herbicides by single and mixed commercial surfactants.
Galán-Jiménez MC; Gómez-Pantoja E; Morillo E; Undabeytia T
Sci Total Environ; 2015 Dec; 538():262-9. PubMed ID: 26311582
[TBL] [Abstract][Full Text] [Related]
32. Thermodynamics of aggregate formation between a non-ionic polymer and ionic surfactants: An isothermal titration calorimetric study.
Patel SG; Bummer PM
Int J Pharm; 2017 Jan; 516(1-2):131-143. PubMed ID: 27789368
[TBL] [Abstract][Full Text] [Related]
33. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
[TBL] [Abstract][Full Text] [Related]
34. Observation of curcumin-loaded hydroxypropyl methylcellulose (HPMC) oleogels under in vitro lipid digestion and in situ intestinal absorption in rats.
Chuesiang P; Zhang J; Choi E; Yoon IS; Kim JT; Shin GH
Int J Biol Macromol; 2022 May; 208():520-529. PubMed ID: 35337911
[TBL] [Abstract][Full Text] [Related]
35. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
36. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
Van Eerdenbrugh B; Taylor LS
Mol Pharm; 2010 Aug; 7(4):1328-37. PubMed ID: 20536263
[TBL] [Abstract][Full Text] [Related]
37. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
38. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
39. Interaction of a cationic acrylate polymer with caseins: biphasic effect of Eudragit E100 on the stability of casein micelles.
Ausar SF; Bianco ID; Castagna LF; Alasino RV; Beltramo DM
J Agric Food Chem; 2003 Jul; 51(15):4417-23. PubMed ID: 12848519
[TBL] [Abstract][Full Text] [Related]
40. Leaching of Lopinavir Amorphous Solid Dispersions in Acidic Media.
Li N; Ormes JD; Taylor LS
Pharm Res; 2016 Jul; 33(7):1723-35. PubMed ID: 27026009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
